Extended Data Table 5 pCR and mPR rates for the ITT population

From: Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial

  1. CI, confidence interval; CT, platinum-doublet chemotherapy; Dato-DXd, datopotamab deruxtecan; mPR, major pathological response; pCR, pathological complete response; Plt, single agent platinum chemotherapy.
Back to article page